title: Chromosomal damage and polymorphisms of DNA repair genes XRCC1 and XRCC3 in workers exposed to cytostatics.
abstract: OBJECTIVE
  Medical workers in oncological units have chronically been exposed to low doses of cytostatics (C) with potential consequences on DNA and chromosomal integrity. Our study addresses relationships between chromosomal aberrations (CAs), chromosome (CSA), and chromatid (CTA) types and polymorphisms in DNA repair genes XRCC1 and XRCC3.
  
  
  METHODS
  The study was conducted on 72 exposed individuals from hospitals in Martin (HMT; 28 individuals), Ruzomberok (HRK; 31 medical workers) and in Trstená (HTS; 13 individuals), and on 34 unexposed individuals. Conventional cytogenetic analysis was employed for the detection of CAs. XRCC1 and XRCC3 polymorphisms were assayed for by Taqman SNP genotyping assays ("Assay-by-Demand") using Real-Time allelic discrimination on AB 7 500 equipment (all from Applied Biosystems, Foster City, USA).
  
  
  RESULTS
  Higher frequencies of CAs were detected in exposed individuals than in controls (1.78% versus 1.32%, respectively). The frequency of aberrant cells (Ab.c.) was highest among workers from HRK (1.97%), followed by those from HMT and HTS (1.54% and 1.85 %, respectively). In the exposed group a moderately higher frequency of CTA (0.93%) in comparison with CSA (0.85%) was detected. Higher CAs were detected in individuals with homozygous variant polymorphism in XRCC1 exon 10 gene than in those with wild-type genotype (1.87% versus 1.60%). Variant T allele in XRCC3 exon 7 was also associated with higher CAs (1.71% and 1.74%) as compared to the wild-type C allele (1.45%).
  
  
  CONCLUSIONS
  The detection of individuals with increased susceptibility to genotoxic agents enables to take preventive measures during the working process.
authors.affiliation: Department of Medical Biology, Comenius University, Jessenius Faculty of Medicine Martin, Slovakia. musak@jfmed.uniba.sk
authors.forename: L'udovít
authors.initials: L
authors.lastname: Musák
authors.forename: Pavel
authors.initials: P
authors.lastname: Vodicka
authors.forename: Gabriela
authors.initials: G
authors.lastname: Klimentová
authors.forename: Pavel
authors.initials: P
authors.lastname: Soucek
authors.forename: Monika
authors.initials: M
authors.lastname: Hánová
authors.forename: Renáta
authors.initials: R
authors.lastname: Mikulková
authors.forename: Janka
authors.initials: J
authors.lastname: Buchancová
authors.forename: Ludmila
authors.initials: L
authors.lastname: Vodicková
authors.forename: Veronika
authors.initials: V
authors.lastname: Poláková
authors.forename: Martin
authors.initials: M
authors.lastname: Péc
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000633:toxicity*; D002877:Chromosomes, Human; D004249:DNA Damage; D004268:DNA-Binding Proteins / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D008505:Medical Staff, Hospital; D008875:Middle Aged; D009784:Occupational Diseases / Q000139:chemically induced*; D016273:Occupational Exposure; D016522:Oncology Service, Hospital; D011110:Polymorphism, Genetic; D000076105:X-ray Repair Cross Complementing Protein 1
chemical_list: D000970:Antineoplastic Agents; D004268:DNA-Binding Proteins; D000076105:X-ray Repair Cross Complementing Protein 1; C110901:X-ray repair cross complementing protein 3; C000619371:XRCC1 protein, human